Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11308268 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
Condition: Myelodysplastic Syndrome
Intervention: Drug: Darbepoetin alfa
2 Unknown  Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
Conditions: Prostatic Neoplasms;   Anemia
Intervention: Drug: Darbepoetin Alfa

Indicates status has not been verified in more than two years